These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1786145)

  • 1. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.
    Parekh BS; Shaffer N; Pau CP; Abrams E; Thomas P; Pollack H; Bamji M; Kaul A; Schochetman G; Rogers M
    AIDS; 1991 Oct; 5(10):1179-84. PubMed ID: 1786145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda.
    Epstein H; Guay L; Hom D; Mmiro F; Ndugwa C; Marum L; Olness K; Piwowar E; Kataaha P; Baenziger J
    Pediatr AIDS HIV Infect; 1994 Dec; 5(6):350-6. PubMed ID: 11361376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal antibodies to HIV-1 envelope domains: No correlation with HIV-1 vertical transmission in patients from Argentina.
    Calarota SA; Libonatti OV
    Scand J Immunol; 2000 Sep; 52(3):292-7. PubMed ID: 10972906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection.
    De Rossi A; Zanotto C; Mammano F; Ometto L; Del Mistro A; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):221-8. PubMed ID: 7682425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
    Wang XP; Oyaizu N; Pahwa S
    Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between anti-V3 loop antibody and perinatal HIV-1 transmission in Kinshasa, Zaire, despite use of assays based on local HIV-1 strains.
    St Louis ME; Pau CP; Nsuami M; Ou CY; Matela B; Kashamuka M; Brown C; George JR; Heyward WL
    J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):63-7. PubMed ID: 8263755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.
    Robertson CA; Mok JY; Froebel KS; Simmonds P; Burns SM; Marsden HS; Graham S
    J Infect Dis; 1992 Oct; 166(4):704-9. PubMed ID: 1527406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
    Vogel T; Kurth R; Norley S
    J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K; Sällberg M; Sönnerborg A
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies of HIV-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (V3) of gp120.
    Boudet F; Girard M; Theze J; Zouali M
    Int Immunol; 1992 Feb; 4(2):283-94. PubMed ID: 1377948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission.
    Fiore JR; Jansson M; Scarlatti G; Angarano G; Caputo SL; Buccoliero G; Rossi P; Fenyö EM; Pastore G
    AIDS; 1993 Jan; 7(1):29-31. PubMed ID: 7680206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.
    Rossi P; Moschese V; Broliden PA; Fundaró C; Quinti I; Plebani A; Giaquinto C; Tovo PA; Ljunggren K; Rosen J
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8055-8. PubMed ID: 2479014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An enzyme-linked immunosorbent assay determining anti-principal neutralizing determinant antibodies using synthetic peptides deduced from cDNA sequences of HIV-1 V3 loop domain].
    Ishimoto S; Fujimura Y; Yamanaka T; Shimoyama T; Nishida S; Matsuoka H; Nishikawa K; Yoshioka A; Narita N; Honda M
    Rinsho Ketsueki; 1995 Mar; 36(3):193-9. PubMed ID: 7540222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation.
    Tian H; Xiao Y; Qin L; Chen YH
    Immunobiology; 2001 Dec; 204(4):434-41. PubMed ID: 11776398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal transmission of HIV type 1: associations with maternal anti-HIV serological reactivity. Mothers and Infants Cohort Study and the HIV-1 Perinatal Serology Working Group.
    Goedert JJ; Dublin S
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1125-34. PubMed ID: 7530026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission.
    Halsey NA; Markham R; Wahren B; Boulos R; Rossi P; Wigzell H
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):153-7. PubMed ID: 1732507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.